Antonia Sánchez-Bautista

ORCID: 0000-0002-6432-3496
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Antibiotic Use and Resistance
  • Cystic Fibrosis Research Advances
  • Poxvirus research and outbreaks
  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Tracheal and airway disorders
  • Liver Disease Diagnosis and Treatment
  • Pancreatitis Pathology and Treatment
  • Hemoglobinopathies and Related Disorders
  • Bacillus and Francisella bacterial research
  • Viral Infections and Vectors
  • Infectious Diseases and Mycology
  • Mycobacterium research and diagnosis
  • Nail Diseases and Treatments
  • Diabetes and associated disorders
  • Iron Metabolism and Disorders
  • Vector-borne infectious diseases
  • Rabies epidemiology and control
  • Bacterial biofilms and quorum sensing
  • Clostridium difficile and Clostridium perfringens research
  • Viral Infections and Outbreaks Research
  • Yersinia bacterium, plague, ectoparasites research

Instituto de investigación sanitaria y biomédica de Alicante
2016-2024

Dirección Regional de Salud del Callao
2024

Hospital General Universitario de Alicante Doctor Balmis
2006-2019

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
2016-2018

Carbapenem-resistant Pseudomonas aeruginosa infections represent a critical public health concern, highlighting the need for development of effective antibiotics. Cefiderocol demonstrated potent in vitro activity against aeruginosa, particularly strains that are resistant to other drugs. However, concerns regarding emergence drug-resistant persist. This study, conducted with 109 carbapenem-resistant from Spanish Hospital (Dr. Balmis, Alicante). The study evaluated susceptibility cefiderocol...

10.3390/antibiotics13070663 article EN cc-by Antibiotics 2024-07-18

ABSTRACT Rapid microbiological diagnosis of the antibiotic susceptibility Gram-negative bacilli is a priority in clinical microbiology, especially cases bacteremia. The rapid advancement antimicrobial resistance proposes challenge for empirical therapy and shows need fast diagnostics to guide treatments. QuickMIC System (Gradientech AB, Uppsala, Sweden) recently developed diagnostic tool testing. Our study evaluates phenotypic system (QuickMIC) that provides information on 12 antibiotics...

10.1128/spectrum.04011-23 article EN cc-by Microbiology Spectrum 2024-08-28

Human mobility drives the spread of many infectious diseases, yet health impacts changes in due to new infrastructure development are poorly understood and currently not accounted for impact assessments. We take a novel quasi-experimental approach identifying link between disease, leveraging historical road upgrades as proxy regional human changes. analyzed how highway paving altered transmission dengue-a high-burden mosquito-borne disease-via movement Madre de Dios region Peru. The...

10.1101/2024.11.15.24317406 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-11-18

Pseudomonas aeruginosa shows resistance to several antibiotics and often develops such during patient treatment.Develop an in vitro model, using clinical isolates of P. aeruginosa, compare the ability imipenem imipenem/relebactam generate resistant mutants other antibiotics. Perform a genotypic analysis detect how selective pressure changes their genomes.The was studied by microdilution assays e-test, study performed NGS.The acquired average 6 days, 12 days (p value = 0.004). After 30...

10.3390/antibiotics12111619 article EN cc-by Antibiotics 2023-11-11
Coming Soon ...